BCPC — Balchem Income Statement
0.000.00%
- $4.87bn
- $4.96bn
- $953.68m
- 98
- 29
- 65
- 70
Annual income statement for Balchem, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 704 | 799 | 942 | 922 | 954 |
| Cost of Revenue | |||||
| Gross Profit | 224 | 243 | 280 | 302 | 336 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 592 | 672 | 797 | 763 | 771 |
| Operating Profit | 111 | 128 | 145 | 159 | 183 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | 106 | 125 | 134 | 137 | 166 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | 84.6 | 96.1 | 105 | 109 | 128 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | 84.6 | 96.1 | 105 | 109 | 128 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | 84.6 | 96.1 | 105 | 109 | 128 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | 2.68 | 2.97 | 3.32 | 3.29 | 3.95 |
| Dividends per Share |